Monogenic hypertension

Monogenic hypertension

Authors

  • Vincenza Precone MAGI Euregio, Bolzano, Italy
  • Geraldo Krasi MAGI Balkans, Tirana, Albania
  • Giulia Guerri MAGI’s Lab, Rovereto (TN), Italy
  • Liborio Stuppia Department of Psychological Sciences, Health and Territory, University “G. d’Annunzio”, Chieti-Pescara, Italy
  • Francesco Romeo Division of Cardiology, University of Rome Tor Vergata, Rome, Italy
  • Marco Perrone Division of Cardiology, University of Rome Tor Vergata, Rome, Italy
  • Carla Marinelli MAGI’s Lab, Rovereto (TN), Italy
  • Alessandra Zulian MAGI’s Lab, Rovereto (TN), Italy
  • Tiziano Dallavilla MAGI’s Lab, Rovereto (TN), Italy
  • Matteo Bertelli MAGI Euregio, Bolzano, Italy

Keywords:

Hypertension, apparent mineralocorticoid excess, hyperaldosteronism, congenital adrenal hyperplasia, Liddle syndrome, pseudohypoaldosteronism

Abstract

Hypertension is a significant public health problem. Thirty percent of cases are caused by a single genetic mutation. Hypertension is the predominant and usually the only manifestation in monogenic hypertension Monogenic hypertension may involve mineralcorticoid-dependent or -independent increase in Na+ transport. Diagnosis is based on routine physical examination, blood pressure measurement and laboratory analysis of renin, aldosterone, cortisol and potassium. Genetic testing is useful for confirming diagnosis and for differential diagnosis. Monogenic hypertension has autosomal dominant or autosomal recessive inheritance.

Downloads

Published

30-09-2019

How to Cite

1.
Precone V, Krasi G, Guerri G, Stuppia L, Romeo F, Perrone M, et al. Monogenic hypertension. Acta Biomed [Internet]. 2019 Sep. 30 [cited 2024 Jul. 18];90(10-S):50-2. Available from: https://mattioli1885journals.com/index.php/actabiomedica/article/view/8759